Portfolio in Urogynaecology

About Syner-Med

Syner-Med is a private, UK-based biopharmaceutical company founded in 2018, specializing in the late-stage development and commercialization of medicines and medical devices. Its business model centers on in-licensing assets and advancing them through clinical development and regulatory approval, primarily within the Vascular Access, Urology, and Urogynaecology sectors. The company appears to be in a commercial or near-commercial stage, generating revenue through its marketed products and partnerships. Its strategy is heavily reliant on establishing international distribution networks to reach global healthcare markets.

Therapeutic Areas